Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
SHANGHAI PECHEM
00338
5
SINOPEC CORP
00386
| (Q1)Mar 31, 2026 | (FY)Dec 31, 2025 | (Q9)Sep 30, 2025 | (Q6)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | -7.62%571.44M | -8.71%2.45B | -8.47%1.9B | -7.48%1.29B | -4.25%618.54M | 1.70%2.68B | 4.69%2.07B | 7.00%1.4B | 5.68%646M | 25.27%2.63B |
| Operating income | -7.62%571.44M | -8.71%2.45B | -8.47%1.9B | -7.48%1.29B | -4.25%618.54M | 1.70%2.68B | 4.69%2.07B | 7.00%1.4B | 5.68%646M | 25.27%2.63B |
| Cost of sales | ---- | 9.39%-734.73M | ---- | 6.63%-386.36M | ---- | -3.77%-810.88M | ---- | -9.10%-413.82M | ---- | -19.02%-781.4M |
| Operating expenses | -2.09%-192.47M | 9.39%-734.73M | 8.38%-562.36M | 6.63%-386.36M | 5.20%-188.52M | -3.77%-810.88M | -9.24%-613.79M | -9.10%-413.82M | -14.13%-198.87M | -19.02%-781.4M |
| Gross profit | -11.87%378.97M | -8.41%1.71B | -8.51%1.34B | -7.83%906.28M | -3.83%430.02M | 0.82%1.87B | 2.90%1.46B | 6.14%983.3M | 2.32%447.12M | 28.10%1.85B |
| Selling expenses | 16.49%-161.92M | -4.35%-814.82M | -1.02%-600.54M | 3.18%-392.38M | 2.74%-193.89M | 4.13%-780.85M | 4.98%-594.49M | 3.72%-405.27M | 0.51%-199.35M | -19.86%-814.51M |
| Administrative expenses | 3.25%-85.36M | 3.11%-433.07M | 0.52%-323.56M | 1.90%-206.19M | -6.99%-88.23M | -5.83%-446.98M | -3.76%-325.24M | -4.76%-210.19M | 11.94%-82.47M | -4.20%-422.35M |
| Research and development expenses | -7.37%-51.99M | 17.22%-197.78M | 20.75%-149.1M | 21.53%-98.4M | 25.40%-48.42M | -8.56%-238.93M | -22.04%-188.14M | -23.68%-125.4M | -21.03%-64.9M | -20.81%-220.1M |
| Profit from asset sales | -94.83%18.59K | ---- | -91.37%18.82K | ---- | 1,089.78%359.5K | ---- | -57.97%217.99K | ---- | -9,233.48%-36.32K | ---- |
| Revaluation surplus | 231.77%391.1K | ---- | 143.11%148.89K | ---- | 125.57%117.88K | ---- | -116.05%-345.33K | ---- | -182.99%-461.1K | ---- |
| -Changes in the fair value of other assets | 231.77%391.1K | ---- | 143.11%148.89K | ---- | 125.57%117.88K | ---- | -116.05%-345.33K | ---- | -182.99%-461.1K | ---- |
| Impairment and provision | 53.55%-3.05M | -307.27%-4.62M | -19.94%-15.38M | -557.93%-2.17M | -7,479.64%-6.57M | 12.98%2.23M | -69.47%-12.83M | 110.30%473K | 103.74%89.04K | 112.72%1.97M |
| -Other impairment is provision | 53.55%-3.05M | -307.27%-4.62M | -19.94%-15.38M | -557.93%-2.17M | -7,479.64%-6.57M | 12.98%2.23M | -69.47%-12.83M | 110.30%473K | 103.74%89.04K | 112.72%1.97M |
| Special items of operating profit | 650.59%17.68M | -104.02%-3.18M | 70.08%42.92M | 27.79%34.26M | -39.08%2.36M | -32.27%78.96M | -10.17%25.23M | -50.63%26.81M | -63.44%3.87M | 54.51%116.57M |
| Operating profit | -3.09%90.7M | -46.58%258.11M | -20.92%279.51M | -10.50%241.39M | -7.02%93.6M | -6.19%483.22M | 3.76%353.45M | 6.54%269.71M | 5.05%100.66M | 121.81%515.1M |
| Financing income | -17.56%11.27M | ---- | -5.51%51.86M | ---- | -23.59%13.67M | ---- | -4.76%54.88M | ---- | -6.77%17.89M | ---- |
| Financing cost | 8.93%-2.3M | -4.52%-18.88M | 6.75%-8.37M | 24.25%-5.7M | 5.61%-2.52M | -147.58%-18.06M | -96.82%-8.98M | -104.87%-7.52M | -154.05%-2.67M | ---7.3M |
| Share of profits of associates | ---- | -98.99%10K | ---- | -120.33%-62K | ---- | 116.23%986K | ---- | -6.44%305K | ---- | 51.50%456K |
| Special items of earning before tax | 79.58%-97.9K | ---- | 1,897.84%19.61M | ---- | -82.44%-479.55K | ---- | -246.17%-1.09M | ---- | -131.68%-262.85K | ---- |
| Earning before tax | -6.84%96.26M | -48.68%239.25M | -10.59%345.5M | -10.23%235.63M | -9.49%103.33M | -8.29%466.15M | -0.75%386.44M | 5.08%262.49M | 1.85%114.16M | 115.61%508.26M |
| Tax | ---- | 65.60%-30.92M | ---- | 24.24%-33.97M | ---- | 6.34%-89.9M | ---- | -9.06%-44.83M | ---- | -111.46%-95.99M |
| After-tax profit from continuing operations | -14.50%71.66M | -44.63%208.32M | -6.81%294.47M | -7.35%201.67M | -9.38%83.81M | -8.74%376.24M | -3.36%315.98M | 4.30%217.66M | 8.87%92.49M | 116.61%412.27M |
| Earning after tax | -14.50%71.66M | -44.63%208.32M | -6.81%294.47M | -7.35%201.67M | -9.38%83.81M | -8.74%376.24M | -3.36%315.98M | 4.30%217.66M | 8.87%92.49M | 116.61%412.27M |
| Minority profit | 70.79%-1.9M | 3.43%-42.69M | 59.14%-10.18M | 46.67%-9.4M | -28.67%-6.5M | -1,047.56%-44.2M | -15,245.51%-24.91M | -610.57%-17.63M | -233.88%-5.05M | -139.06%-3.85M |
| Profit attributable to shareholders | -18.55%73.56M | -40.30%251.01M | -10.63%304.65M | -10.29%211.07M | -7.41%90.31M | 1.04%420.45M | 4.31%340.89M | 14.64%235.28M | 20.16%97.54M | 130.58%416.12M |
| Basic earnings per share | -17.95%0.32 | -40.00%1.08 | -10.27%1.31 | -9.90%0.91 | -7.14%0.39 | 2.86%1.8 | 6.57%1.46 | 17.44%1.01 | -10.64%0.42 | 68.27%1.75 |
| Diluted earnings per share | -17.95%0.32 | -40.00%1.08 | -10.27%1.31 | -9.90%0.91 | -7.14%0.39 | 2.86%1.8 | 6.57%1.46 | 17.44%1.01 | -10.64%0.42 | 68.27%1.75 |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | IAS | CAS (2007) | IAS | CAS (2007) | IAS | CAS (2007) | IAS | CAS (2007) | IAS |
| Audit Opinions | -- | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- | Unqualified Opinion |
| Auditor | -- | -- | -- | -- | -- | Ernst & Young Huaming Certified Public Accountants (Special General Partnership) | -- | -- | -- | Ernst & Young Huaming Certified Public Accountants (Special General Partnership) |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.